Advantis Corp: Struggling Pharma Player in Medical Cannabis Market
Advantis Corp’s $878 market cap and $0.00001 stock show limited trading, but its medical‑cannabis focus could unlock upside if FDA approvals and new funding arrive.
2 minutes to read